Company Name: Voyager Therapeutics, Inc.   

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The company is engaged in the development of adeno-associated virus (AAV) gene therapies designed to treat central nervous system disorders.  The company’s pipeline includes product candidates for:

  • Friedreich’s ataxia
  • Huntington’s disease
  • Monogenic form of amyotrophic lateral sclerosis (ALS)
  • Parkinson’s disease
  • Spinal muscular atrophy (SMA)

Ticker Symbol: VYGR (NASDAQ)

Company Website: www.voyagertherapeutics.com

Social Media: Voyager Therapeutics LinkedIn

Headquarters: Cambridge, MA